Cargando…
Efficacy and Safety of Dotinurad in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Introduction A systematic review and meta-analysis of the available randomized controlled trials (RCTs) were conducted to investigate the efficacy and safety of dotinurad in hyperuricemic patients with or without gout. Dotinurad is a novel selective urate reabsorption inhibitor (SURI) that increases...
Autores principales: | Iqbal, Ayman, Iqbal, Kinza, Farid, Eisha, Ishaque, Ali, Hasanain, Muhammad, Bin Arif, Taha, Arshad Ali, Shajeea, Rathore, Sawai Singh, Malik, Mehreen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114961/ https://www.ncbi.nlm.nih.gov/pubmed/33996294 http://dx.doi.org/10.7759/cureus.14428 |
Ejemplares similares
-
Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout
por: Hosoya, Tatsuo, et al.
Publicado: (2019) -
The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
por: Iqbal, Ayman, et al.
Publicado: (2021) -
A non-inferiority study of the novel selective urate reabsorption inhibitor dotinurad versus febuxostat in hyperuricemic patients with or without gout
por: Hosoya, Tatsuo, et al.
Publicado: (2020) -
Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
por: Hosoya, Tatsuo, et al.
Publicado: (2020) -
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
por: Hosoya, Tatsuo, et al.
Publicado: (2019)